This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shasun Pharmaceuticals Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: N Subramanian: Innovator in Antipsychotic Compounds
Introduction
N Subramanian is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for antipsychotic medications. His work is characterized by a focus on innovative chemical formulations that enhance therapeutic efficacy.
Latest Patents
N Subramanian holds a patent for "Salts and hydrates of antipsychotics." This invention relates to a novel salt of a specific compound, (3aR,4S,7R,7aS)-2-[((1R,2R)-2-{[4-(1,2-benzisothiazol-3-yl)-piperazin-1-yl]methyl}cyclohexyl)methyl]hexahydro-1H-4,7-methanisoindol-1,3-dione, and its hydrates. The patent outlines methods for preparing this novel salt and its hydrates, providing a process for the preparation of lurasidone dihydrochloride. The process includes mixing lurasidone free base in an organic solvent system, subjecting the mixture to an acid proton source, and isolating the compound of lurasidone dihydrochloride.
Career Highlights
N Subramanian is associated with Shasun Pharmaceuticals Limited, where he applies his expertise in pharmaceutical chemistry. His innovative approach has led to advancements in the development of antipsychotic medications, contributing to improved treatment options for patients.
Collaborations
Some of his coworkers include Vijayabaskar Veerappan and Srimurugan Sankareswaran, who collaborate with him on various projects within the pharmaceutical sector.
Conclusion
N Subramanian's contributions to the field of antipsychotic compounds exemplify the impact of innovation in pharmaceuticals. His patent for lurasidone dihydrochloride showcases his commitment to enhancing mental health treatment through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile